中国实用儿科杂志2024，Vol.39Issue(11)：820-825,6.DOI:10.19538/j.ek2024110604
男性先天性低促性腺激素性性腺功能减退症的全生命周期管理
Comprehensive life-cycle management of male congenital hypogonadotropic hypogonadism
摘要
Abstract
Congenital hypogonadotropic hypogonadism(CHH)is primarily characterized by manifestations such as micropenis,cryptorchidism,and partial or complete lack of development of secondary sexual characteristics.The disease has a complex pathogenesis and exhibits a wide range of clinical phenotypes.Treatment focus and protocols vary across different stages of life and clinical phenotypes.Timely diagnosis and appropriate treatment are beneficial to sexual development,bone and metabolic health,and may also help to mitigate some of the psychological impacts of CHH.关键词
先天性低促性腺激素性性腺发育不良/下丘脑-垂体-性腺轴/脉冲式促性腺激素释放激素治疗/重组人促卵泡激素Key words
congenitalhypogonadotropic hypogonadism/hypothalamic-pituitary-gonadal axis/pulsatile gonadotropin-releasing hormone therapy(pulsatile GnRH therapy)/recombinant human follicle-stimulating hormone分类
医药卫生引用本文复制引用
苏尉,苏喆..男性先天性低促性腺激素性性腺功能减退症的全生命周期管理[J].中国实用儿科杂志,2024,39(11):820-825,6.基金项目
广东省卫生健康委员会高水平临床重点专科项目(SZGSP012) （SZGSP012）
深圳市科技计划资助可持续发展项目(KCXFZ20201221173400002) （KCXFZ20201221173400002）
